Vonoprazan–minocycline dual therapy as a first-line treatment of infection compared with empirical bismuth-containing quadruple therapy
Background: Increasing antibiotic resistance compromises therapeutic options for Helicobacter pylori ( H. pylori ) infection, especially in penicillin-allergic individuals. Objectives: This trial aimed to assess the efficacy and safety of 14-day vonoprazan–minocycline (VM) dual therapy against bismu...
Saved in:
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
SAGE Publishing
2025-08-01
|
| Series: | Therapeutic Advances in Gastroenterology |
| Online Access: | https://doi.org/10.1177/17562848251366156 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|